Early Life
Ugur Sahin was born on September 19, 1965, in İskenderun, Turkey. At the age of four, he moved to Germany with his mother to join his father in Cologne. He excelled in academics, graduating from the Erich-Kästner-Gymnasium in Cologne-Niehl in 1984. During his time at the Saarland University Hospital, he met his future wife, Özlem Türeci.
Rise to Success
Sahin's career began in academia, where he worked as a physician in internal medicine and hematology/oncology from 1991 to 2000 at the University Hospital of Cologne and the Saarland University Hospital in Homburg. He habilitated in molecular medicine and immunology in 1999. In 2001, Sahin co-founded Ganymed Pharmaceuticals with his wife, Özlem Türeci, and Christoph Huber. In 2008, he co-founded BioNTech with Özlem Türeci and Christoph Huber. His leadership in the development of the BNT162b2 mRNA vaccine against COVID-19, in partnership with Pfizer, propelled BioNTech to global prominence.
Key Business Strategies
Key strategies include pioneering mRNA technology for personalized cancer therapy and developing RNA vaccine nanoparticle delivery strategies. His ability to identify and respond to the COVID-19 pandemic led to the rapid development and approval of the vaccine. He led BioNTech to start on a vaccine for the coronavirus in early 2020; it partnered with Pfizer in March 2020 and got approval in December.
Philanthropy
While the search results did not provide specific amounts for Ugur Sahin's philanthropy, he and his wife are known for their modest lifestyle. They still live in a modest apartment and ride bicycles to work, indicating a focus on causes rather than lavish spending. In 2019, BioNTech announced a $55 million partnership with the Bill and Melinda Gates Foundation to develop new treatments for HIV and tuberculosis.
